Sales forces dwindle at top pharmas

Share this article:
In an Associated Press tally, seven out of the 12 companies surveyed reported reductions in work force by 10% or more since January 2007.  

Respondents included Pfizer, Johnson & Johnson and AstraZeneca. Schering-Plough and Wyeth have both made recent announcements regarding job cuts in their sales departments.

According to Craig Scott, CEO of TargetRx, reducing sales forces may not be the best way to foster industry convalescence, but it should shift the focus away from basic “activity levels,” toward a more optimal sales performance: quality products presented to physicians in a quality way.

“Cost cutting through sales and marketing layoffs is convenient in the short term but won't solve the root problem for pharmaceutical companies. The work that we have done at TargetRx indicates that improving the quality of sales and marketing yields almost five times more of an increase in physician prescribing than increasing the volume of sales and marketing activity. This underscores a clear opportunity for any company that needs to reduce spending.” 
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features


Reimagining healthcare? We want to hear about it.
 
Submit nominations here for MM&M's first-ever list of the Top 40 Healthcare Transformers

Email Newsletters

MM&M inVISION

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

Upward Move: Jose Rivera

Upward Move: Jose Rivera

Jose Rivera. EVP, account director, Concentric